Data for this study were sourced from previously published data from 395 girls or women combined with a replication sample of 248 girls or women specifically recruited for this study.
USPSTF determines that more research is needed to recommend for or against screening in people without symptoms and provides updates on effective screening tools and pharmacotherapies.
Investigators with the US CDC examined electronic medical records from emergency departments participating in the National Syndromic Surveillance Program (NSSP).
Researchers examined the effect of neuropeptides orexin-A, ghrelin, and neuropeptide Y on hypersomnia and hyperphagia. Both symptoms are more common in people with bipolar disorder.
The US Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for making a recommendation for or against screening for eating disorders.
With the last review of the global burden of mental disorders published in 2013, updates in methodology, epidemiological databases, and burden estimation were included in the 2019 review.
Compared with 2019, there were declines in weekly ED visits associated with mental health conditions (MHCs) during 2020, followed by variation in specific MHCs by age and sex during 2021 and January 2022.
National Eating Disorders Awareness Week is intended to increase awareness about eating disorders and inform how to best care for people with them. A recent summit discussed some of the barriers to eating disorder care for patients and health care professionals alike. What were some areas for improvement noted at the summit?
With a lack of studies exploring the possible mediating role of psychological factors, such as depression, anxiety and stress on orthorexic eating behaviors, researchers investigated the mediating effect of depression, anxiety, and stress, on impulsivity and orthorexia nervosa, and healthy orthorexia.
Investigators assessed the presence of unhealthy eating behaviors in adolescents with obesity undergoing bariatric surgery, with or without nonalcoholic fatty liver disease.